UK markets closed

Fresenius Medical Care AG & Co. KGaA (FMS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
35.46-0.04 (-0.11%)
At close: 4:00PM EDT
35.46 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 520.51B
Enterprise value 334.05B
Trailing P/E 17.74
Forward P/E 113.97
PEG ratio (5-yr expected) 11.96
Price/sales (ttm)1.02
Price/book (mrq)1.52
Enterprise value/revenue 31.96
Enterprise value/EBITDA 78.96

Trading information

Stock price history

Beta (5Y monthly) 1.01
52-week change 3-14.49%
S&P500 52-week change 330.48%
52-week high 344.13
52-week low 333.84
50-day moving average 336.23
200-day moving average 339.14

Share statistics

Avg vol (3-month) 3378.91k
Avg vol (10-day) 3356.8k
Shares outstanding 5585.96M
Implied shares outstanding 6N/A
Float 8397.34M
% held by insiders 10.00%
% held by institutions 13.80%
Shares short (29 Sept 2021) 4798.73k
Short ratio (29 Sept 2021) 42.63
Short % of float (29 Sept 2021) 4N/A
Short % of shares outstanding (29 Sept 2021) 40.14%
Shares short (prior month 30 Aug 2021) 41.46M

Dividends & splits

Forward annual dividend rate 40.82
Forward annual dividend yield 42.31%
Trailing annual dividend rate 31.34
Trailing annual dividend yield 33.77%
5-year average dividend yield 4N/A
Payout ratio 474.70%
Dividend date 306 Jun 2021
Ex-dividend date 423 May 2021
Last split factor 22:1
Last split date 303 Dec 2012

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021


Profit margin 5.76%
Operating margin (ttm)11.58%

Management effectiveness

Return on assets (ttm)3.74%
Return on equity (ttm)9.51%

Income statement

Revenue (ttm)17.34B
Revenue per share (ttm)29.61
Quarterly revenue growth (yoy)-5.20%
Gross profit (ttm)5.54B
Net income avi to common (ttm)998.21M
Diluted EPS (ttm)1.98
Quarterly earnings growth (yoy)-37.70%

Balance sheet

Total cash (mrq)1.41B
Total cash per share (mrq)2.4
Total debt (mrq)13.12B
Total debt/equity (mrq)102.36
Current ratio (mrq)1.05
Book value per share (mrq)19.85

Cash flow statement

Operating cash flow (ttm)2.46B
Levered free cash flow (ttm)1.28B